1
项与 AXL-TILs(Guangdong Zhaotai InVivo Biomedicine) 相关的临床试验Engineered TILs/CAR-TILs With PD1 Knockout and Anti-PD1/CTLA4-scFv Secreting or CARs Against Various Antigens to Treat Advanced Solid Tumors
Tumor infiltration lymphocytes (TILs) have been harvested from advanced cancer patients and constructed to knockout PD1 gene and express scFvs against both PD1 and CTALA4 and CARs against various antigens, followed by transfusion into the patients. The safety, tolerance, and preliminary clinical efficacy of the TILs will be evaluated.
100 项与 AXL-TILs(Guangdong Zhaotai InVivo Biomedicine) 相关的临床结果
100 项与 AXL-TILs(Guangdong Zhaotai InVivo Biomedicine) 相关的转化医学
100 项与 AXL-TILs(Guangdong Zhaotai InVivo Biomedicine) 相关的专利(医药)
100 项与 AXL-TILs(Guangdong Zhaotai InVivo Biomedicine) 相关的药物交易